News
Pomerantz LLP is investigating claims on behalf of investors of Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR). Such investors are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback